topSkip to main content

Menu, Secondary

Menu Trigger

Menu

National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and influenza.

 

The Ad Hoc Group for Medical Research, which includes AAU, issued a statement supportive of the $15.5 billion include in Senate Republicans’ pandemic relief plan.
United for Medical Research, of which AAU is a member, released a statement praising Senate Republicans for including $15.5 for NIH in their COVID-19 relief proposal.
The letter urges the board to consider the importance of human fetal tissue research to develop new tests, treatments, and cures to “reduce suffering from human diseases” during their evaluation of the ethics of research proposals using human fetal tissue
United for Medical Research, which includes AAU, released a statement thanking the House Appropriations Committee Labor-Health and Human Services-Education subcommittee for approving a $5.5. billion increase for the NIH.
The Ad Hoc Group for Medical Research released a statement thanking the House Appropriations Committee Labor-Health and Human Services-Education subcommittee for recognizing that the NIH remains a “key national priority despite the restrictive subcommittee funding allocation imposed by the impractical pre-pandemic discretionary spending caps.”
This table represents the current status of FY21 appropriations for AAU’s funding priorities at the Departments of Education, Energy, and Defense as well as the National Institutes of Health (NIH), National Science Foundation (NSF), NASA, AFRI, and the National Endowment for the Humanities (NEH).
The Ad Hoc Group for Medical Research sent a letter to congressional appropriations leaders urging them to “significantly boost” the FY21 302(b) allocations for the Labor-Health and Human Services-Education spending bill.
AAU joined the Council on Governmental Relations to submit a letter to the National Library of Medicine regarding its request for information on the modernization of “ClinicalTrials.gov.”
Biomedical research supported by the National Institutes of Health (NIH) and performed at research universities helps ensure U.S. leadership in the life sciences revolution of the 21st Century.
The Ad Hoc Group for Medical Research, which includes AAU, released a statement recommending Congress fund NIH at $44.7 billion in FY21.